Title : Calcineurin inhibitor attenuates cardiac hypertrophy due to energy metabolic disorder.

Pub. Date : 2001 Dec

PMID : 11773940






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Treatment with calcineurin inhibitor FK506 (0.5 or 1.0 mg/kg/day) from the age of four to eight weeks attenuated cardiac hypertrophy without beneficially affecting cardiac function. Tacrolimus calcineurin binding protein 1 Mus musculus